REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT05568459 updates: 1. completion date: 2026-05-21 → 2026-08-21 2. primary completion date: 2026-05-21 → 2026-08-21
Clinical trial NCT05568459 updates: 1. completion date: 2026-05-21 → 2026-08-21 2. primary completion date: 2026-05-21 → 2026-08-21
📉 **NEGATIVE** • Medium confidence analysis (62%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical